Description

Giefoni 250mg Tablet (Geftinib) – Uses, Side Effects, Dosage & Price in Pakistan

Giefoni 250mg Tablet (Geftinib) is an oral prescription medicine associated with gefitinib, a targeted cancer medicine known as an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Gefitinib is used for certain patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have specific EGFR mutations. Molecular testing helps determine whether a patient is likely to benefit from this treatment.

This guide explains Giefoni 250mg Tablet, including its uses, dosage, how it works, side effects, precautions, interactions, price in Pakistan, availability, and important safety information.

What Is Giefoni 250mg Tablet?

Giefoni 250mg Tablet is a targeted oral cancer medicine associated with gefitinib 250mg. Gefitinib belongs to the tyrosine kinase inhibitor class and works by blocking specific signals involved in the growth of cancer cells.

It is mainly used for patients with metastatic NSCLC whose tumors have eligible EGFR mutations, particularly exon 19 deletions or exon 21 L858R substitution mutations. Testing of tumor or plasma samples may be performed before treatment to identify these mutations.

The exact manufacturer, formulation, packaging, and active ingredient should always be confirmed from the original product packaging before use.

Giefoni 250mg (Geftinib) Uses

The main use of Giefoni 250mg is associated with the treatment of certain cases of metastatic non-small cell lung cancer.

Gefitinib may be prescribed when appropriate testing confirms an eligible EGFR mutation, including:

• EGFR exon 19 deletion
• EGFR exon 21 L858R substitution mutation
• Certain metastatic NSCLC cases where targeted EGFR treatment is appropriate

Gefitinib is not suitable for every lung cancer patient. The tumor’s molecular characteristics are important when deciding whether this medicine should be used. Official prescribing information recommends selecting patients based on specific EGFR mutation findings.

How Does Giefoni 250mg Work?

Giefoni 250mg works through inhibition of the EGFR tyrosine kinase pathway.

EGFR is a protein involved in cellular signaling and growth. Some lung cancer cells contain activating EGFR mutations that can cause abnormal signaling and support cancer-cell growth.

Gefitinib blocks EGFR tyrosine kinase activity, reducing signals that may contribute to the growth and survival of EGFR-mutated cancer cells. This targeted mechanism is why molecular testing is important before treatment.

Giefoni 250mg Dosage

The recommended dose of gefitinib is 250mg taken orally once daily, with or without food. Treatment is generally continued until disease progression or unacceptable toxicity, according to the treating healthcare professional.

Do not change the prescribed dose or take extra tablets without medical advice.

If a dose is missed and the next dose is due within 12 hours, the missed dose should not be taken.

How to Take Giefoni 250mg Tablet?

Take Giefoni 250mg exactly as prescribed by your oncologist.

The tablet may be taken with or without food. Taking it at approximately the same time each day can help maintain a consistent treatment routine.

For patients who have difficulty swallowing tablets, official prescribing information describes dispersing the tablet in 4 to 8 ounces of water and stirring for approximately 15 minutes before administration. Follow your healthcare professional’s instructions when using this method.

Do not alter the tablet or change the administration method without professional guidance.

Giefoni 250mg (Geftinib) Side Effects

Like other targeted cancer medicines, Giefoni 250mg may cause side effects. Their severity can vary between patients.

Commonly reported effects associated with gefitinib may include:

• Diarrhea
• Skin rash
• Acne-like skin reactions
• Dry skin
• Reduced appetite
• Nausea
• Vomiting
• Mouth irritation
• Weakness
• Changes in liver function tests

Some side effects may improve with appropriate medical management, while others may require treatment interruption or adjustment.

Contact your healthcare provider if side effects become severe, persistent, or difficult to manage.

Important Safety Information for Giefoni 250mg

Gefitinib can cause serious adverse reactions, including interstitial lung disease, hepatotoxicity, gastrointestinal perforation, severe diarrhea, and ocular disorders such as keratitis.

Seek prompt medical attention if you experience:

• New or worsening shortness of breath
• New or worsening cough
• Fever with breathing difficulties
• Severe or persistent diarrhea
• Yellowing of the skin or eyes
• Severe abdominal pain
• Significant eye pain or vision changes
• Severe skin reactions

If interstitial lung disease is confirmed, gefitinib should be permanently discontinued according to the prescribing information. Other serious reactions may also require treatment interruption or discontinuation under medical supervision.

Giefoni 250mg Precautions

Before starting treatment, tell your healthcare provider about your medical history and all medicines or supplements you are taking.

Particular attention may be required if you have:

• Liver problems
• Previous lung disease
• Persistent diarrhea
• Eye problems
• Gastrointestinal disorders
• Other serious medical conditions

Periodic liver function monitoring may be recommended during treatment.

Gefitinib can also cause fetal harm. Patients who can become pregnant should discuss effective contraception with their healthcare professional. Breastfeeding should also be discussed because treatment may require avoiding breastfeeding.

Giefoni 250mg Interactions

Some medicines can affect gefitinib levels in the body and may change its effectiveness or increase the risk of side effects.

Tell your doctor about all prescription medicines, over-the-counter products, vitamins, and supplements you use.

Strong CYP3A4 inducers can affect gefitinib exposure, and dose management may be required by the treating physician. Do not start, stop, or change another medicine without discussing it with your healthcare team.

Giefoni 250mg (Geftinib) Price in Pakistan

The Giefoni 250mg price in Pakistan may vary depending on the manufacturer, pack size, supplier, availability, and market conditions.

The price of products containing gefitinib can also change over time because of import and supply factors. When checking the Giefoni 250mg price in Pakistan, patients should consider more than cost alone.

Before purchasing, verify the product name, active ingredient, strength, manufacturer, packaging, batch information, and expiry date.

Giefoni 250mg in Pakistan

People searching for Giefoni 250mg in Pakistan may find different product listings and pharmaceutical suppliers.

Availability can vary, so the product should be checked carefully before purchase. Prescription cancer medicines should be obtained from reliable pharmaceutical sources and used under the supervision of a qualified healthcare professional.

Because the standard active ingredient name is gefitinib, users may also search online using terms such as Giefoni 250mg, gefitinib 250mg, gefitinib tablets, and gefitinib 250mg in Pakistan.

How to Buy Giefoni 250mg in Pakistan?

If you are searching for Giefoni 250mg buy in Pakistan, choose a reliable pharmaceutical source that provides clear product information.

Impo Medic provides medicine-related information and product details for customers searching for pharmaceutical products in Pakistan. Before purchasing Giefoni 250mg, check the packaging, manufacturer, active ingredient, strength, expiry date, and other product details.

Since this is a prescription cancer medicine, it should only be used according to the treatment plan provided by a qualified healthcare professional.

Why Choose Impo Medic?

Impo Medic focuses on making medicine-related information easier to understand for customers in Pakistan. Our product pages provide useful information about ingredients, uses, dosage, precautions, possible side effects, and purchasing considerations.

For people searching for Giefoni 250mg Tablet (Geftinib), Giefoni 250mg price in Pakistan, or information about gefitinib products in Pakistan, Impo Medic aims to provide a clear and convenient source of product information.

Frequently Asked Questions About Giefoni 250mg

What Is Giefoni 250mg Tablet Used For?

Giefoni 250mg is associated with gefitinib, which is used for the first-line treatment of certain patients with metastatic NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R substitution mutations.

What Is the Recommended Giefoni 250mg Dosage?

The recommended gefitinib dose is 250mg orally once daily, with or without food. The treating healthcare professional determines how long treatment should continue.

What Are the Common Giefoni 250mg Side Effects?

Common side effects associated with gefitinib can include diarrhea, skin rash, dry skin, nausea, reduced appetite, mouth irritation, weakness, and changes in liver function tests.

Can Giefoni 250mg Be Taken With Food?

Yes. Gefitinib 250mg can be taken with or without food. It is generally helpful to take the medicine consistently at around the same time each day.

Is Giefoni 250mg Used for Lung Cancer?

Yes. Gefitinib is used for certain patients with metastatic non-small cell lung cancer when eligible EGFR mutations are identified through appropriate testing.

Is Giefoni 250mg Available in Pakistan?

Availability may vary between pharmaceutical suppliers and pharmacies in Pakistan. Product authenticity, manufacturer information, packaging, and expiry details should be checked before purchase.

What Is the Giefoni 250mg Price in Pakistan?

The price can vary according to manufacturer, pack size, availability, and supplier. For the latest price, check with a reliable pharmaceutical source.

Is Giefoni 250mg the Same as Gefitinib?

The product information supplied for this article identifies Giefoni 250mg with Geftinib; however, the internationally recognized generic name in official labeling is gefitinib. Always verify the active ingredient printed on the actual product packaging before use.